Key result
Mannitol is linked to an ~8 mm Hg reduction in intracranial pressure in severe hemorrhagic stroke.
Observational (n=12)
Answers are grounded in this paper and cite their sources.
Retrospective review reveals mannitol lowers intracranial pressure and improves metabolic stress markers in comatose haemorrhagic stroke patients, indicating metabolic benefits beyond pressure relief.
BACKGROUND: The impact of osmotic therapies on brain metabolism has not been extensively studied in humans. The authors examined if mannitol treatment of raised intracranial pressure will result in an improvement in brain metabolism together with the expected drop in intracranial pressure (ICP). METHODS: This is a retrospective review of prospectively collected data. Twenty episodes of raised ICP (>20 mm Hg) resistant to standard therapy that required infusions of mannitol were studied in 12 comatose patients with multimodality monitoring including ICP, PbtO(2) and microdialysis. The authors compared mean arterial blood pressure, ICP, cerebral perfusion pressure, PbtO(2), brain lactate, pyruvate and glucose using cerebral microdialysis, for 3 h preceding and 4 h after hyperosmolar therapy. Time-series data were analysed using a multivariable general linear model utilising generalised estimating equations for model estimation to account for within-subjects and between-subjects variations over time. RESULTS: 20% mannitol solution (1 g/kg) was administered at the discretion of the attending neurointensivist. ICP decreased 30 min (from 27 ± 13 to 19 ± 16 mm Hg, p<0.001) and cerebral perfusion pressure increased 45 min (from 73 ± 18 to 85 ± 22 mm Hg, p=0.002) after the start of mannitol infusions, whereas mean arterial blood pressure and PbtO(2) did not change significantly. The peak lactate-pyruvate ratio was recorded at the time of initiating osmotherapy (44 ± 20) with an 18% decrease over 2 h following mannitol therapy (35 ± 16; p=0.002). Brain glucose remained unaffected. CONCLUSIONS: Mannitol effectively reduces ICP and appeared to benefit brain metabolism as measured by the lactate-pyruvate ratio.
No takes yet. Share an insight, caveat, or question.
Helbok et al. (2010) conducted an observational in Severe haemorrhagic stroke with raised intracranial pressure (n=12). Mannitol vs. Pre-treatment baseline was evaluated on Intracranial pressure (ICP) at 30 minutes (p=<0.001). Mannitol administration in severe haemorrhagic stroke decreased intracranial pressure from 27 to 19 mm Hg and reduced the brain lactate-pyruvate ratio from 44 to 35.
Synapse has enriched 10 related papers. Consider them for comparative context: